TOP2B and neoplasm: Dox anticancer effects are mainly related to topoisomerase IIα inhibition rather than this pro-oxidant effect [3,5], whereas in non-tumor cells, topoisomerase IIβ inhibition and oxidative stress are considered the main mechanisms [3,7,8,9,10,11].